Erik Emerson
Fortuna: 458 612 $ al 31/08/2026
Fortuna: 458 612 $ al 31/08/2026
Mr. Erik Emerson is a Chief Executive Officer & Director at GlucoTrack, Inc. and a Chief Executive Officer & Director at Lokahi Therapeutics, Inc. He is on the Board of Directors at GlucoTrack, Inc. and Lokahi Therapeutics, Inc. Mr. Emerson was previously employed as a President & Director by Apimeds Pharmaceuticals US, Inc., a Chief Commercial Officer by Odyssey Health, Inc., a Chief Commercial Officer by Mezzion Pharmaceuticals, Inc., a President & Chief Executive Officer by Symplmed Pharmaceuticals LLC, a Senior Director-Commercial Development by XOMA Corp., and a Marketing Director by Gilead Sciences, Inc. He also served on the board at Adhera Therapeutics, Inc. He received his undergraduate degree from the University of Oregon.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
4,97 % | 15/10/2025 | 75.000 ( 4,97 % ) | 291 000 $ | 31/08/2026 |
GLUCOTRACK INC 4,94 % | 10/08/2026 | 39.438 ( 4,94 % ) | 167 612 $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| GLUCOTRACK, INC. | Director Ejecutivo | 14/07/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
| ODYSSEY HEALTH, INC. | Corporate Officer/Principal | 01/10/2023 |
Mezzion Pharmaceuticals, Inc.
Mezzion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a drug manufacturing company | Corporate Officer/Principal | 01/01/2020 |
| ADHERA THERAPEUTICS, INC. | Director/Miembro de la Junta | 19/12/2019 |
Symplmed Pharmaceuticals LLC
Symplmed Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Director Ejecutivo | 01/05/2018 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 8 |
|---|---|
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
XOMA Royalty Corp.
XOMA Royalty Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops antibody therapeutics | Health Technology |
GlucoTrack, Inc.
GlucoTrack, Inc. Medical SpecialtiesHealth Technology Develops a non-invasive glucose monitoring device | Health Technology |
Odyssey Health, Inc.
Odyssey Health, Inc. Medical SpecialtiesHealth Technology Develops heart monitoring and screening devices | Health Technology |
University of Oregon
University of Oregon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adhera Therapeutics, Inc.
Adhera Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes hypertensive drugs | Health Technology |
Symplmed Pharmaceuticals LLC
Symplmed Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Mezzion Pharmaceuticals, Inc.
Mezzion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a drug manufacturing company | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.